MENU

NERV Minerva Neurosciences Forecast, Technical & Fundamental Analysis

a clinical-stage biopharmaceutical company

Industry Biotechnology
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NERV is expected to report earnings to fall 67.34% to 97 cents per share on March 18

Minerva Neurosciences NERV Stock Earnings Reports
Q4'24
Est.
$0.97
Q3'24
Beat
by $3.98
Q2'24
Missed
by $0.12
Q1'24
Missed
by $0.12
Q4'23
Missed
by $0.31
The last earnings report on November 05 showed earnings per share of $2.97, beating the estimate of -100 cents. With 22.16K shares outstanding, the current market capitalization sits at 15.32M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1500 District Avenue
Phone
+1 617 600-7373
Employees
9
Web
https://www.minervaneurosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

NERV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with ASPHF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then ASPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
+4.57%
ASPHF - NERV
44%
Loosely correlated
N/A
NRXP - NERV
24%
Poorly correlated
+36.67%
BZYR - NERV
22%
Poorly correlated
+16.74%
BPTH - NERV
22%
Poorly correlated
+3.60%
RVMD - NERV
21%
Poorly correlated
+1.01%
More